FA-8 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with FA-8
B
- B-Donna Tablets (atropine / hyoscyamine / phenobarbital / scopolamine)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Bactrim IV (sulfamethoxazole / trimethoprim)
- Bactrim Pediatric (sulfamethoxazole / trimethoprim)
- Banzel (rufinamide)
- Barbidonna (atropine / hyoscyamine / phenobarbital / scopolamine)
- Bel-Phen-Ergot (belladonna / ergotamine / phenobarbital)
- Bel-Tabs (belladonna / ergotamine / phenobarbital)
- belladonna / ergotamine / phenobarbital
- Bellalphen (atropine / hyoscyamine / phenobarbital / scopolamine)
- Bellamine (belladonna / ergotamine / phenobarbital)
- Bellamine S (belladonna / ergotamine / phenobarbital)
- Bellamor (belladonna / ergotamine / phenobarbital)
- Bellaphen-S (belladonna / ergotamine / phenobarbital)
- Bellaspas (belladonna / ergotamine / phenobarbital)
- Bellatal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Bellatal ER (atropine / hyoscyamine / phenobarbital / scopolamine)
- Bellergal-S (belladonna / ergotamine / phenobarbital)
- Bethaprim (sulfamethoxazole / trimethoprim)
- Bethaprim Pediatric (sulfamethoxazole / trimethoprim)
More about FA-8 (folic acid)
- FA-8 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.